| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...747067K |
| P356 | DOI | 10.1371/JOURNAL.PONE.0047067 |
| P932 | PMC publication ID | 3480380 |
| P698 | PubMed publication ID | 23115635 |
| P5875 | ResearchGate publication ID | 232746183 |
| P50 | author | Felicity C. Kalinowski | Q55294173 |
| P2093 | author name string | Peter J Leedman | |
| Alishum Ali | |||
| Clarissa Ganda | |||
| Keith M Giles | |||
| Michael R Epis | |||
| Patrick A Candy | |||
| Rebecca J Webster | |||
| P2860 | cites work | A new human cell line (FaDu) from a hypopharyngeal carcinoma. | Q52829962 |
| microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. | Q54364560 | ||
| EGFR inhibition as a therapy for head and neck squamous cell carcinoma | Q94706770 | ||
| MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells | Q24597324 | ||
| miRNAs in human cancer | Q24628889 | ||
| Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma | Q24646667 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer | Q26852215 | ||
| Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. | Q27851397 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 | ||
| MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions | Q28297593 | ||
| Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7 | Q28303603 | ||
| CK2 binds, phosphorylates, and regulates its pivotal substrate Cdc37, an Hsp90-cochaperone | Q28581892 | ||
| The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
| Gene silencing by microRNAs: contributions of translational repression and mRNA decay | Q29615825 | ||
| Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck | Q29619277 | ||
| Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7. | Q30425986 | ||
| miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways | Q30428483 | ||
| VASCo: computation and visualization of annotated protein surface contacts. | Q30486213 | ||
| The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma | Q30494514 | ||
| Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue | Q33331288 | ||
| Platinum-based chemotherapy plus cetuximab in head and neck cancer | Q33381094 | ||
| Predicting microRNA targets in time-series microarray experiments via functional data analysis | Q33407825 | ||
| A PCR primer bank for quantitative gene expression analysis | Q33447710 | ||
| Preparation of pure cell cultures by cloning | Q33888007 | ||
| AKT plays a central role in tumorigenesis | Q33944165 | ||
| Understanding resistance to EGFR inhibitors-impact on future treatment strategies | Q34088424 | ||
| TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer | Q34100276 | ||
| Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck | Q34287207 | ||
| MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression | Q34372477 | ||
| MicroRNAs and endocrine biology | Q34486152 | ||
| Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck | Q34533587 | ||
| Global microRNA level regulation of EGFR-driven cell-cycle protein network in breast cancer | Q34635861 | ||
| Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer | Q34816422 | ||
| MicroRNA alterations in head and neck squamous cell carcinoma. | Q35253630 | ||
| The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells | Q35842164 | ||
| Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer | Q35875753 | ||
| MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review | Q36037933 | ||
| Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck | Q36045386 | ||
| Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions | Q37072581 | ||
| New promising molecular targets in head and neck squamous cell carcinoma | Q37983463 | ||
| MicroRNA expression profiles in head and neck cancer cell lines | Q38302158 | ||
| The role of serum response factor in hepatocellular carcinoma: Implications for disease progression | Q38482033 | ||
| Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells | Q39386176 | ||
| Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastom | Q39442732 | ||
| Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells | Q39516392 | ||
| MicroRNA Regulation of Growth Factor Receptor Signaling in Human Cancer Cells | Q39646854 | ||
| Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib | Q39707468 | ||
| Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell lines | Q40067422 | ||
| Protein kinase CK2 phosphorylates and upregulates Akt/PKB. | Q40437202 | ||
| Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines | Q40486711 | ||
| The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells | Q40527345 | ||
| The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. | Q40685410 | ||
| Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells | Q40895491 | ||
| Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors | Q41161192 | ||
| Signal transduction through MAP kinase cascades | Q41750250 | ||
| Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. | Q42498478 | ||
| Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas | Q42801605 | ||
| Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments | Q43719931 | ||
| Determination of subcutaneous tumor size in athymic (nude) mice | Q46296687 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erlotinib | Q418369 |
| head and neck cancer | Q1783924 | ||
| head and neck carcinoma | Q18554836 | ||
| neck cancer | Q18966654 | ||
| P304 | page(s) | e47067 | |
| P577 | publication date | 2012-10-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7 | |
| P478 | volume | 7 |
| Q38612171 | A miR-7/GAS6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma. |
| Q90098458 | Biogenesis, functions and clinical significance of circRNAs in gastric cancer |
| Q39069286 | CHO cell culture longevity and recombinant protein yield are enhanced by depletion of miR-7 activity via sponge decoy vectors |
| Q33766123 | Circular RNAs: Biogenesis, Function and Role in Human Diseases. |
| Q26797306 | Clinical Potential of microRNA-7 in Cancer |
| Q28542713 | Differential transcriptional effects of EGFR inhibitors |
| Q28066531 | EGF receptor ligands: recent advances |
| Q47584658 | Evaluation of MicroRNA Delivery In Vivo. |
| Q58115914 | Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis |
| Q88923213 | Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers |
| Q26798882 | Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer? |
| Q52659385 | Long noncoding RNA RP4 functions as a competing endogenous RNA through miR-7-5p sponge activity in colorectal cancer. |
| Q38391456 | MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma |
| Q36546760 | MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma |
| Q35965465 | MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis. |
| Q26796592 | MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression |
| Q58923813 | MicroRNAs in Cancer Drug Resistance and Drug Sensitivity |
| Q38186568 | MicroRNAs: master regulators of drug resistance, stemness, and metastasis. |
| Q37707666 | Roles of mitochondrial transcription factor A and microRNA‑590‑3p in the development of colon cancer |
| Q93069186 | Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ |
| Q28392330 | Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma |
| Q34334362 | Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma |
| Q38272718 | The molecular mechanisms and therapeutic potential of microRNA-7 in cancer |
| Q38172182 | Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks |
| Q41549459 | miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression |
| Q35021427 | miR-331-3p regulates expression of neuropilin-2 in glioblastoma |
| Q37619788 | miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways |
| Q37000569 | microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8 |
| Q37362485 | microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB. |
Search more.